[1]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68-70.
 LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68-70.
点击复制

益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
26
期数:
2013年07期
页码:
68-70
栏目:
报道·临证经验
出版日期:
2013-07-15

文章信息/Info

Title:
Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy
文章编号:
1004-6852(2013)07-0068-03
作者:
林晓芬黄燕璇
汕头市龙湖区下蓬医院内科,广东 汕头 515065
Author(s):
LIN Xiaofen HUANG Yanxuan
Department of Internal Medicine of Xiapeng Hospital in Longhu District, Shantou 515065, China
关键词:
糖尿病肾病早期益肾汤厄贝沙坦胰激肽原酶
Keywords:
early diabetic nephropathy YiShenTang irbesartan pancreatic kininogenase
分类号:
R587.2
文献标志码:
A
摘要:
目的:观察益肾汤联合厄贝沙坦、胰激肽原酶治疗早期糖尿病肾病(DN)的疗效。方法:将66例早期DN患者随机分为治疗组(n=36)和对照组(n=30)。对照组使用厄贝沙坦联合胰激肽原酶进行治疗,治疗组在对照组的基础上加用益肾汤治疗。2组疗程均为2个月。观察并比较2组患者的治疗效果和治疗前后平均动脉压(MAP)、空腹血糖(FBG)、血肌酐(Scr)、尿素氮(BUN)、尿白蛋白排泄率(UAER)、尿β2-微球蛋白(β2-MG)的变化。结果:总有效率治疗组为88.9%,对照组为76.7%,2组差异虽无显著性(P>0.05),但治疗组总有效率高于对照组。2组治疗前后Scr、BUN保持稳定。与治疗前比较,治疗1个月后2组MAP、UAER及β2-MG均明显下降(P<0.01)。与治疗1个月后比较,治疗2个月后2组UAER及β2-MG水平仍继续下降(P<0.05或P<0.01)。与对照组比较,治疗组治疗1、2个月后UAER、β2-MG下降程度更明显(P<0.01)。结论:益肾汤联合厄贝沙坦、胰激肽原酶治疗早期DN患者疗效确切,且能更有效地降低UAER和β2-MG水平,是延缓早期DN进展的有效办法。
Abstract:
Objective: To observe curative efficacy of YiShenTang, irbesartan and pancreatic kininogenase in treating early diabetic nephropathy(DN). Method: All 66 patient were randomized into the treatment group (n=36) and the control group(n=30). The patients in the control group were administered with irbesartan and pancreatic kininogenase, while the treatment group took YiShenTang. Two months were one course of treatment. The changes of urinary beta2-microglobulin (β2-MG), urinary albumin excretion rate (UAER), usea nitrogen (BUN), serum creatinine (Scr), fasting blood glucose (FBG) and mean arterial pressure (MAP) were compared before and after treating in both groups, as well as clinical effects. Result: Total effective rate of the treatment group was 88.9%, higher than 76.7% of the control group, the difference was insignificant(P>0.05). Scr and BUN of both groups were stable before and after treating. Compared with before treating, MAP, UAER and β2-MG were lowered remarkably after treating for one month(P<0.01). Compared with after treating for one month, UAER and β2-MG of both groups continued to lower after treating for two months (P<0.05 or P<0.01). Compared with the control group, UAER and β2-MG of both groups were decreased more significantly in the treatment group(P<0.01). Conclusion: YiShenTang, irbesartan and pancreatic kininogenase could obtain notable effects in treating patients with early DN, it could effectively decrease the levels of UAER and β2-MG, it is an effective method to delay the progress of DN.

相似文献/References:

[1]朱苗蕊,指导:金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
 ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):74.
[2]张鉴明.加味生化汤联合米非司酮、米索前列醇治疗早期妊娠药物流产200例[J].西部中医药,2013,26(04):77.
 ZHANG Jianming.Modified ShengHuaTang Combined with Mifepristone and Misoprostol in Treating 200 Cases of Drug Abortion for Patients in Early Pregnancy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):77.
[3]徐宏.益水生新饮对高血压早期肾损害患者血液流变学及ALB和α1-MG的影响*[J].西部中医药,2013,26(06):4.
 XU Hong.Effects of Y iShui ShengXinY in on Hemorheology, ALB and α1-MG of Hypertensive Patients with Early Renal Damage[J].Western Journal of Traditional Chinese Medicine,2013,26(07):4.
[4]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
 LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68.
[5]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
 MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):96.
[6]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
 WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):62.
[7]梁彩霞.胃肠道术后早期肠内营养的观察分析[J].西部中医药,2013,26(09):131.
 LIANG Caixia.Analysis and Observation on Early Enteral Nutrition Applied to the Patients with Gastrointestinal Surgery[J].Western Journal of Traditional Chinese Medicine,2013,26(07):131.
[8]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
 REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1.
[9]杨华,曾娟花.血清TNF与2型糖尿病肾病及其中医证型关系的临床研究[J].西部中医药,2014,27(01):11.
 YANG Hua,ZENG Juanhua.Clinical Study on the Relationship between Serum TNF and Type 2 Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):11.
[10]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
 REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):77.
[11]王永军,石良静,等.益气养阴通络方对早期糖尿病肾病患者炎症因子及肾功能的影响[J].西部中医药,2020,33(05):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
 WANG Yongjun,SHI Liangjing,FAN Zhengchao,et al.Influence of Qi-invigorating Yin-nourishing Collateral-dredging Prescription on Inflammatory Factors and Renal Function of the Patients with Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(07):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
[12]朱祎,李晓华.叶氏益肾降糖方治疗早期糖尿病肾病疗效观察[J].西部中医药,2020,33(07):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]
 ZHU Yi,LI Xiaohua.Clinical Effects of Ye′s Yishen Jiangtang Prescription in Treating Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(07):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]

备注/Memo

备注/Memo:
收稿日期:2013-02-01 作者简介:林晓芬(1975—),女,主治医师。研究方向:糖尿病、肾病的中西医结合诊治。
更新日期/Last Update: 2013-07-15